Fortress Biotech (FBIO) Net Margin (2015 - 2026)
Fortress Biotech (FBIO) posted quarterly Net Margin of 44.1% for Q4 2025, up 1957.0% year-over-year from 2.14% in Q4 2024, and down 311.55% quarter-over-quarter from 20.84% in Q3 2025.
Powered by 
Analysis
Fortress Biotech (FBIO) Net Margin (2015 - 2026) Analysis & Trends
Fortress Biotech's Net Margin history runs 11 years deep, the most recent figure standing at 44.1% for Q4 2025.
- In Q4 2025, Net Margin rose 1957.0% year-over-year to 44.1%; the TTM figure through Dec 2025 stood at 3.15% (up 9369.0% YoY), while the FY2025 annual figure was 3.07%, up 9383.0% from the prior year.
- Net Margin for Q4 2025 stood at 44.1%, down from 20.84% in the prior quarter.
- The five-year high for Net Margin was 88.98% in Q2 2025, with the low at 29336.13% in Q2 2021.
- The 5-year median for Net Margin is 115.47% (2022), against an average of 3418.84%.
- The sharpest annual moves came in 2021 and 2022: Net Margin slumped 2903879 bps in 2021, then jumped 2920800 bps in 2022.
- Fortress Biotech's Net Margin stood at 102.34% in 2021, then jumped by 149 bps to 50.4% in 2022, then tumbled by 247 bps to 73.98% in 2023, then increased by 14 bps to 63.66% in 2024, then surged by 31 bps to 44.1% in 2025.
- Business Quant data shows FBIO's Net Margin at 44.1% in Q4 2025, 20.84% in Q3 2025, and 88.98% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 12.09% |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | -3.12% |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn | -13.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.23% |
| Dec 31, 2025 | -38.55% |
| Sep 30, 2025 | 20.84% |
| Jun 30, 2025 | 81.37% |
| Mar 31, 2025 | -96.77% |
| Dec 31, 2024 | -63.84% |
| Sep 30, 2024 | -102.81% |
| Jun 30, 2024 | -89.55% |
| Mar 31, 2024 | -137.06% |
| Dec 31, 2023 | -56.59% |
| Sep 30, 2023 | -20.30% |
| Jun 30, 2023 | -154.82% |
| Mar 31, 2023 | -189.44% |
| Dec 31, 2022 | -176.22% |
| Sep 30, 2022 | -148.35% |
| Jun 30, 2022 | -128.13% |
| Mar 31, 2022 | -206.80% |
| Dec 31, 2021 | -373.56% |
| Sep 30, 2021 | -257.22% |
| Jun 30, 2021 | -254.84% |